SEC Tracker
Get the app

Helus Pharma HELP

Helus Pharma announces new developments

Foreign issuer report

Form
6-K
Filed
Importance
Routine
  1. Incorporates Exhibit 99.1 by reference
  2. Signed by Chief Financial Officer Greg Cavers
  3. Filed under Form 6-K for October 2026

Written from the 6-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Helus Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX